Perspective
Improving Medicare Advantage by Accounting for Large Differences in Upcoding Across Plans
February 3, 2025
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
Research
All Research Featured Research
Perspective
How the Next President Should Reform Medicare
September 25, 2024
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
Perspective
Estimating Overpayments to MA Plans: MedPAC Critics Get It Wrong
July 1, 2024
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
White Paper
Fixing Medicare Advantage With Competitive Bidding
June 12, 2024
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
Perspective
Improving Access to Medigap When Beneficiaries Leave Medicare Advantage
April 26, 2024
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
Perspective
Knowing Actual Prices Will Help HHS Set the Maximum Fair Price under the Inflation Reduction Act
February 16, 2024
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Perspective
Lowering Medicare Advantage Overpayments from Favorable Selection by Reforming Risk Adjustment
July 13, 2023
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD, Eugene Lin, MD, MS
Perspective
Favorable Selection Ups the Ante on Medicare Advantage Payment Reform
June 13, 2023
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
White Paper
Medicare Advantage Enrolls Lower-Spending People, Leading to Large Overpayments
June 13, 2023
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Data Visualization
Substantial Growth in Medicare Advantage and Implications for Reform
February 6, 2023
Featured Experts: Erin Trish, PhD, Paul Ginsburg, PhD, Samantha Randall, Steve M. Lieberman, MPhil, MA
Perspective
Sharing Drug Rebates With Medicare Part D Patients: Why And How
September 15, 2020
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD, Erin Trish, PhD
Perspective
Considerations For Expanding International Reference Pricing Beyond Medicare Part B
September 9, 2019
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Perspective
The Use of Vendors in Medicare Part B Drug Payment
August 2, 2019
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
Perspective
CMS’s International Pricing Model for Medicare Part B Drugs: Implementation Issues
July 9, 2019
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
White Paper
A Proposal to Enhance Competition and Reform Bidding in the Medicare Advantage Program
May 10, 2018
Featured Experts: Steve M. Lieberman, MPhil, MA, Erin Trish, PhD, Paul Ginsburg, PhD
Brookings Schaeffer on Health Policy
The Case for Reforming Competitive Bidding in Medicare Advantage
May 10, 2018
Featured Experts: Erin Trish, PhD, Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
White Paper
Medicare Advantage: Better Information Tools, Better Beneficiary Choices, Better Competition
November 28, 2017
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA, Erin Trish, PhD
Perspective
A Billion Here, a Billion There: Selectively Disclosing Actual Generic Drug Prices Would Save Real Money
September 12, 2017
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
White Paper
Would Price Transparency for Generic Drugs Lower Costs for Payers and Patients?
June 14, 2017
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Perspective
Four Recommendations to Advance Medicare Delivery System Reform
February 10, 2017
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD